News

Plasma Nutrition partners with New Brunswick Health Research Foundation

30 Jun 2017

Plasma Nutrition has joined a list of companies including AstraZeneca, Eli Lilly, Janssen and Merck, all of whom have partnered with the New Brunswick Health Research Foundation, an independent organisation with a focus on health research.

Plasma Nutrition partners with New Brunswick Health Research Foundation

Plasma Nutrition has joined a list of companies including AstraZeneca, Eli Lilly, Janssen and Merck, all of whom have partnered with the New Brunswick Health Research Foundation, an independent organisation with a focus on health research in New Brunswick, Canada. The purpose of the cooperation is to promote academic research and provide additional scientific foundation for the startup's Ingredient Optimization technology.

"Our mission is not just to disrupt the protein processing industry," said co-founder Chris Flynn-Rozanski. "For us it's equally important to commit to good science that benefits the community. We want our technology to promote positive health outcomes that can be demonstrated through rigorous scientific investigation."

Plasma Nutrition developed a patent pending technology - called Ingredient Optimization - that changes the structure of proteins and increases their bio-efficacy. Currently, its products are targeted at the supplements sector, whose value in the US economy was $121.6 billion in 2016.

At the same time, government agencies and consumers are demanding more transparency regarding the benefits of dietary and sports supplements on the market. This new partnership will allow Plasma Nutrition to meet those expectations by having easier access to research-based feedback from the scientific community.

Plasma Nutrition is the only start-up in NBHRF's selected list of partners, which also includes Pfizer, Sanofi, Novo Nordisk, and Boehringer Ingelheim. "The NBHRF is pleased to collaborate with the private sector such as Plasma Nutrition, a company which has a vision for applied research for health living" says Dr. Bruno Battistini, President, CEO and Scientific Director of NBHRF. "We do this as part of our health research initiative program via our value demonstration initiative funding, engaging the public with the private sector."

"It is very important for us to be a part of the broader scientific community, and working with NBHRF is key to achieving this goal," said Plasma Nutrition co-founder Stephen Motosko. "They've supported many excellent companies and we're excited to join such an exclusive list of private company partners."